Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020

MLA

Lyna Z. Schieber, et al. “Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020.” MMWR. Morbidity and Mortality Weekly Report, vol. 69, Sept. 2020, pp. 1210–15. EBSCOhost, https://doi.org/10.15585/mmwr.mm6935a4.

APA

Lyna Z. Schieber, Lara Bull-Otterson, Macarena C. García, Joseph G. Courtney, Heather Strosnider, Daniel S. Budnitz, Adi V. Gundlapalli, John T. Brooks, William R. Mac Kenzie, & Elizabeth B. Gray. (2020). Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020. MMWR. Morbidity and Mortality Weekly Report, 69, 1210–1215. https://doi.org/10.15585/mmwr.mm6935a4

Chicago

Lyna Z. Schieber, Lara Bull-Otterson, Macarena C. García, Joseph G. Courtney, Heather Strosnider, Daniel S. Budnitz, Adi V. Gundlapalli, John T. Brooks, William R. Mac Kenzie, and Elizabeth B. Gray. 2020. “Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020.” MMWR. Morbidity and Mortality Weekly Report 69 (September): 1210–15. doi:10.15585/mmwr.mm6935a4.